To further determine whether CD13 inhibitors might potentiate the anti-tumor activity of TRAIL via TRAIL-induced apoptosis, we assessed the apoptosis of cells treated with TRAIL in the absence or presence of bestatin or WM15. The gene discussed is TNFSF10; the disease is neoplasm.